10.03.2010 • NewsHexionBilanzsales and profits

Hexion Q4 Net Loss Narrows; Sales Drop

Privately held Hexion Specialty Chemicals said its fourth-quarter net loss narrowed sharply, helped in part by falling costs and improving volume.

For the period, the company posted a net loss of $6 million compared with $921 million in the year-ago period.

The year-ago period includes a one-time charge of $800 million the company paid to Huntsman as part of a settlement to cancel its plans to acquire that company.

Hexion said its asset impairment costs and business realignment costs fell during the period.

Revenue decreased 7.6% to $1.09 billion.

The company said raw material prices were lower and that volume jumped 5%. Volume is the physical amount of product sold.

Hexion is owned by Apollo Management, a private equity firm that also owns the Harrah's casino chain and Norwegian Cruise Lines.

The company said earlier this year it wanted to extend some of its term loans until May 2015 and issue $700 million in senior notes.

Company

Hexion Specialty Chemicals

Gennaerstr. 2-4
58642 Iserlohn
Germany

Company contact







Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read